D015507Chemicals & DrugsD26.371880.993808Drugs, InvestigationalFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentDivisionvivo:hrJobTitleHR job titleInformation ResourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forrdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPerson30586161Hodowanec AC, Pikis A, Komatsu TE, Sampson MR, Younis IR, O'Rear JJ, Singer MEJournal of clinical pharmacologyTreatment and Prevention of CMV Disease in Transplant Recipients: Current Knowledge and Future Perspectives. J Clin Pharmacol. 2019 06; 59(6):784-798.J Clin Pharmacol2018-12-26T00:00:002018Treatment and Prevention of CMV Disease in Transplant Recipients: Current Knowledge and Future Perspectives.true1ProfessorProfessorAdult Health and Gerontological NursingOtolaryngologyKatalinMikeczKatalin Mikecz41.87352120000000-87.66713820000000349080Mikecz, KatalinProfessorLolaCokeLola Coke349218Coke, LolaAssociate ProfessorMelodyCobleighMelody Cobleigh349588Cobleigh, MelodyProfessor6Assistant Professor5Associate Professor4Professor11249574Mikecz KCurrent opinion in investigational drugs (London, England : 2000)Vitaxin applied molecular evolution. Curr Opin Investig Drugs. 2000 Oct; 1(2):199-203.Curr Opin Investig Drugs2000-10-01T00:00:002000Vitaxin applied molecular evolution.32327472Gordon LI, Kaplan JB, Popat R, Burris HA, Ferrari S, Madan S, Patel MR, Gritti G, El-Sharkawi D, Chau I, Radford JA, P?rez de Oteyza J, Zinzani PL, Iyer S, Townsend W, Karmali R, Miao H, Proscurshim I, Wang S, Wu Y, Stumpo K, Shou Y, Carpio C, Bosch FClinical cancer research : an official journal of the American Association for Cancer ResearchPhase I Study of TAK-659, an Investigational, Dual SYK/FLT3 Inhibitor, in Patients with B-Cell Lymphoma. Clin Cancer Res. 2020 07 15; 26(14):3546-3556.Clin Cancer Res2020-04-23T00:00:002020Phase I Study of TAK-659, an Investigational, Dual SYK/FLT3 Inhibitor, in Patients with B-Cell Lymphoma.Neurological SciencesOrthopedic SurgeryRush University, College of NursingRush University, Rush Medical Collegetrue1ProfessorProfessortrue1Assistant ProfessorAssistant ProfessorInternal Medicine, Division of Hematology/Oncology/Cell TherapyDonnaBergenDonna C. Bergen349839Bergen, DonnaProfessorBobbyTajudeenBobby Tajudeen349973Tajudeen, BobbyAssistant Professortrue1ProfessorProfessor28847168Schwartz JS, Tajudeen BA, Cohen NAExpert opinion on investigational drugsMedical management of chronic rhinosinusitis - a review of traditional and novel medical therapies. Expert Opin Investig Drugs. 2017 Oct; 26(10):1123-1130.Expert Opin Investig Drugs2017-09-05T00:00:002017Medical management of chronic rhinosinusitis - a review of traditional and novel medical therapies.true1Associate ProfessorAssociate Professor29634645Lamendola C, Champagne MA, Nelson Worel J, Coke LAThe Journal of cardiovascular nursingAccess to Innovative Medicine: A Preventive Cardiovascular Nurses Association Position Statement to Reduce the Barriers. J Cardiovasc Nurs. 2018 May/Jun; 33(3):199-201.J Cardiovasc Nurs2018-05-01T00:00:002018Access to Innovative Medicine: A Preventive Cardiovascular Nurses Association Position Statement to Reduce the Barriers.0.6597250.02354768research area of0.7614620.023694310subject area for